Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor (Q27710661)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor |
scientific article |
Statements
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor (English)
Jean-Marc Lapierre
Sudharshan Eathiraj
David Vensel
Yanbin Liu
Cathy O Bull
Susan Cornell-Kennon
Shin Iimura
Eugene W Kelleher
Darin E Kizer
Steffi Koerner
Sapna Makhija
Akihisa Matsuda
Magdi Moussa
Nivedita Namdev
Ronald E Savage
Jeff Szwaya
Erika Volckova
Neil Westlund